Sun Pharma – Daily Chart Levels
Immediate Resistance: ₹1,745 – ₹1,755
Major Resistance Zone: ₹1,790 – ₹1,810 (breakout zone for further rally)
Immediate Support: ₹1,705 – ₹1,695
Strong Support Zone: ₹1,660 – ₹1,650
Trend Outlook (Daily)
Stock is trading in a higher-high, higher-low structure, indicating bullish bias.
As long as price holds above ₹1,695, buyers will remain active.
A daily close above ₹1,755 can open the way toward ₹1,790+.
A break below ₹1,695 may bring downside toward ₹1,660.
Immediate Resistance: ₹1,745 – ₹1,755
Major Resistance Zone: ₹1,790 – ₹1,810 (breakout zone for further rally)
Immediate Support: ₹1,705 – ₹1,695
Strong Support Zone: ₹1,660 – ₹1,650
Trend Outlook (Daily)
Stock is trading in a higher-high, higher-low structure, indicating bullish bias.
As long as price holds above ₹1,695, buyers will remain active.
A daily close above ₹1,755 can open the way toward ₹1,790+.
A break below ₹1,695 may bring downside toward ₹1,660.
I built a Buy & Sell Signal Indicator with 85% accuracy.
📈 Get access via DM or
WhatsApp: wa.link/d997q0
| Email: techncialexpress@gmail.com
| Script Coder | Trader | Investor | From India
📈 Get access via DM or
WhatsApp: wa.link/d997q0
| Email: techncialexpress@gmail.com
| Script Coder | Trader | Investor | From India
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
I built a Buy & Sell Signal Indicator with 85% accuracy.
📈 Get access via DM or
WhatsApp: wa.link/d997q0
| Email: techncialexpress@gmail.com
| Script Coder | Trader | Investor | From India
📈 Get access via DM or
WhatsApp: wa.link/d997q0
| Email: techncialexpress@gmail.com
| Script Coder | Trader | Investor | From India
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.